Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial--clinical implications.
Ismail-Beigi
Faramarz
F
Department of Medicine, Case Western Reserve University, Cleveland, OH 44106-4951, USA. fxi2@case.edu
D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment
D015415:Biomarkers; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents